Have a feature idea you'd love to see implemented?
Let us know!
INSP Inspire Medical Systems Inc
Price (delayed)
$195.845
Market cap
$5.84B
P/E Ratio
932.6
Dividend/share
N/A
EPS
$0.21
Enterprise value
$5.68B
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the
Highlights
INSP's EPS has surged by 140% since the previous quarter and by 115% year-on-year
The net income has soared by 138% from the previous quarter and by 115% YoY
INSP's debt is up by 11% YoY
Key stats
What are the main financial stats of INSP
Market
Valuations
Earnings
Shares outstanding
29.82M
Market cap
$5.84B
Enterprise value
$5.68B
Price to earnings (P/E)
932.6
Price to book (P/B)
9.12
Price to sales (P/S)
8.25
EV/EBIT
665.44
EV/EBITDA
416.47
EV/Sales
8.04
Revenue
$705.71M
EBIT
$8.53M
EBITDA
$13.63M
Free cash flow
-$9.42M
Per share
Balance sheet
Liquidity
EPS
$0.21
Free cash flow per share
-$0.32
Book value per share
$21.48
Revenue per share
$23.74
TBVPS
$24.5
Total assets
$728.39M
Total liabilities
$90.32M
Debt
$24.51M
Equity
$638.07M
Working capital
$541.5M
Debt to equity
0.04
Current ratio
9.25
Quick ratio
7.91
Net debt/EBITDA
-12
Margins
Efficiency
Dividend
EBITDA margin
1.9%
Gross margin
84.8%
Net margin
0.9%
Operating margin
-2%
Return on assets
0.9%
Return on equity
1%
Return on invested capital
2%
Return on capital employed
1.3%
Return on sales
1.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INSP stock price
How has the Inspire Medical Systems stock price performed over time
Intraday
-1.63%
1 week
1.75%
1 month
-7.2%
1 year
34.29%
YTD
-3.73%
QTD
-7.2%
Financial performance
How have Inspire Medical Systems's revenue and profit performed over time
Revenue
$705.71M
Gross profit
$598.67M
Operating income
-$14.29M
Net income
$6.01M
Gross margin
84.8%
Net margin
0.9%
The net income has soared by 138% from the previous quarter and by 115% YoY
INSP's net margin has soared by 138% QoQ and by 112% YoY
The operating margin has soared by 80% YoY and by 63% from the previous quarter
The operating income has soared by 73% year-on-year and by 60% since the previous quarter
Growth
What is Inspire Medical Systems's growth rate over time
Valuation
What is Inspire Medical Systems stock price valuation
P/E
932.6
P/B
9.12
P/S
8.25
EV/EBIT
665.44
EV/EBITDA
416.47
EV/Sales
8.04
INSP's EPS has surged by 140% since the previous quarter and by 115% year-on-year
The P/B is 46% below the 5-year quarterly average of 17.1 and 3.4% below the last 4 quarters average of 9.6
The company's equity rose by 21% YoY and by 8% QoQ
The stock's P/S is 62% less than its 5-year quarterly average of 22.0 and 4.7% less than its last 4 quarters average of 8.8
Inspire Medical Systems's revenue has increased by 34% YoY and by 7% from the previous quarter
Efficiency
How efficient is Inspire Medical Systems business performance
INSP's return on sales has surged by 157% since the previous quarter and by 116% year-on-year
INSP's ROIC has soared by 145% from the previous quarter and by 104% YoY
INSP's ROA has soared by 138% from the previous quarter and by 113% YoY
INSP's ROE has soared by 136% since the previous quarter and by 112% year-on-year
Dividends
What is INSP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INSP.
Financial health
How did Inspire Medical Systems financials performed over time
The company's total assets rose by 18% YoY and by 6% QoQ
The current ratio rose by 17% since the previous quarter and by 10% year-on-year
INSP's debt is 96% lower than its equity
The company's equity rose by 21% YoY and by 8% QoQ
INSP's debt is up by 11% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.